GLP-1 Collective

Policy Tracker · Patient Lens · October 12, 2026

Eli Lilly v. Willow Health Services pending in Ninth Circuit

The docket does not say what the dispute is about, and its latest action is dated March 5, 2026.


Key details

  • A lawsuit between Eli Lilly and Company and Willow Health Services, Inc. is pending in the Ninth Circuit, and the latest docket action is dated March 5, 2026.

A lawsuit between Eli Lilly and Company and Willow Health Services, Inc. is pending in the Ninth Circuit Court of Appeals. Eli Lilly makes GLP-1 medications, but the docket does not say what the dispute is actually about, so there is little we can tell you beyond the fact that it exists.

The case, captioned Eli Lilly and Company v. Willow Health Services, Inc., is pending in the Ninth Circuit. Its most recent docket action is dated March 5, 2026. The docket does not describe the subject matter of the dispute, so we cannot say whether it touches on pricing, supply, marketing, patents, or something unrelated to GLP-1 medications. A case being pending simply means it is active and unresolved. It is not a ruling, a settlement, or any kind of finding against either party.

At this stage, the most accurate thing we can tell you is that this case exists and remains unresolved. We would caution against reading anything further into it until more details become available, whether that means the underlying claims, the parties' arguments, or any outcome from the court.

By Amanda Bonello

Originally published by Patient Lens on GLP-1 Laws, operated by GLP-1 Studio LLC — a for-profit company founded by the Collective's Executive Director. Republished here in full, with permission, at no cost. The Collective pays nothing for it and receives no payment for publishing it. How this works.